BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,056 filers reported holding BAXTER INTL INC in Q1 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $151,274 | -17.0% | 4,008 | +0.2% | 0.04% | -11.6% |
| Q2 2023 | $182,240 | +12.3% | 4,000 | 0.0% | 0.04% | +19.4% |
| Q1 2023 | $162,240 | -20.4% | 4,000 | 0.0% | 0.04% | -21.7% |
| Q4 2022 | $203,880 | -5.2% | 4,000 | 0.0% | 0.05% | -51.1% |
| Q3 2022 | $215,000 | -16.3% | 4,000 | 0.0% | 0.09% | +51.6% |
| Q2 2022 | $257,000 | -17.1% | 4,000 | 0.0% | 0.06% | -39.2% |
| Q1 2022 | $310,000 | -9.6% | 4,000 | 0.0% | 0.10% | +47.8% |
| Q4 2021 | $343,000 | +6.5% | 4,000 | 0.0% | 0.07% | -38.4% |
| Q3 2021 | $322,000 | -3.6% | 4,000 | -3.6% | 0.11% | +1.8% |
| Q2 2021 | $334,000 | -35.6% | 4,150 | -32.5% | 0.11% | -40.9% |
| Q1 2021 | $519,000 | +5.3% | 6,150 | 0.0% | 0.19% | +5.1% |
| Q4 2020 | $493,000 | -0.4% | 6,150 | 0.0% | 0.18% | -14.9% |
| Q3 2020 | $495,000 | -6.6% | 6,150 | 0.0% | 0.21% | -10.3% |
| Q2 2020 | $530,000 | +6.2% | 6,150 | 0.0% | 0.23% | -15.6% |
| Q1 2020 | $499,000 | -2.9% | 6,150 | 0.0% | 0.28% | +20.6% |
| Q4 2019 | $514,000 | +0.4% | 6,150 | +5.1% | 0.23% | -71.2% |
| Q3 2019 | $512,000 | +1.6% | 5,850 | -4.9% | 0.79% | +232.4% |
| Q2 2019 | $504,000 | +0.8% | 6,150 | 0.0% | 0.24% | -6.7% |
| Q1 2019 | $500,000 | -11.2% | 6,150 | -28.1% | 0.26% | -20.8% |
| Q4 2018 | $563,000 | -14.6% | 8,550 | 0.0% | 0.32% | -9.8% |
| Q3 2018 | $659,000 | +1.4% | 8,550 | -2.8% | 0.36% | +5.9% |
| Q2 2018 | $650,000 | +13.6% | 8,800 | 0.0% | 0.34% | +9.1% |
| Q1 2018 | $572,000 | +0.5% | 8,800 | 0.0% | 0.31% | +1.0% |
| Q4 2017 | $569,000 | +3.1% | 8,800 | 0.0% | 0.31% | +68.1% |
| Q3 2017 | $552,000 | +3.6% | 8,800 | 0.0% | 0.18% | -1.1% |
| Q2 2017 | $533,000 | +20.9% | 8,800 | +3.5% | 0.18% | +38.3% |
| Q1 2017 | $441,000 | +13.1% | 8,500 | -3.4% | 0.13% | -34.8% |
| Q4 2016 | $390,000 | -6.9% | 8,800 | 0.0% | 0.20% | -4.2% |
| Q3 2016 | $419,000 | +5.3% | 8,800 | 0.0% | 0.21% | -13.8% |
| Q2 2016 | $398,000 | +9.9% | 8,800 | 0.0% | 0.25% | +2.5% |
| Q1 2016 | $362,000 | +9.7% | 8,800 | +1.7% | 0.24% | +10.0% |
| Q4 2015 | $330,000 | +16.2% | 8,650 | 0.0% | 0.22% | +1.9% |
| Q3 2015 | $284,000 | -67.0% | 8,650 | -29.7% | 0.22% | -24.8% |
| Q2 2015 | $860,000 | +0.4% | 12,304 | -1.6% | 0.29% | -43.5% |
| Q1 2015 | $857,000 | -8.6% | 12,504 | -2.3% | 0.51% | -5.4% |
| Q4 2014 | $938,000 | +2.1% | 12,804 | 0.0% | 0.54% | -7.6% |
| Q3 2014 | $919,000 | -2.2% | 12,804 | -1.5% | 0.58% | -1.5% |
| Q2 2014 | $940,000 | -5.4% | 13,004 | -3.7% | 0.59% | -6.2% |
| Q1 2014 | $994,000 | +5.1% | 13,504 | -0.7% | 0.63% | -1.9% |
| Q4 2013 | $946,000 | +7.9% | 13,604 | +1.9% | 0.64% | -7.8% |
| Q3 2013 | $877,000 | -5.9% | 13,354 | -0.7% | 0.69% | +2375.0% |
| Q2 2013 | $932,000 | – | 13,454 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |